A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6 through 11, according to research presented Tuesday at a medical conference and published in the New England Journal of Medicine. Based on the results of the trial, drugmaker Novo Nordisk has asked U.S. regulators to expand use of the medication for kids in that age group, a company spokesperson said Tuesday.
Kentucky Attorney General Russell Coleman unveiled plans Tuesday to create a statewide drug prevention program, saying the youth-focused initiative would fill a hole in the Bluegrass State's fight against an addiction epidemic that has claimed thousands of lives. Coleman presented the plan's details to a state commission, which unanimously approved his request for a $3.6 million investment over two years to implement it. “With over one million Kentuckians under the age of 18, we are going to put every single dollar to good use,” Coleman said.
MEXICO CITY (AP) — As Mexican senators weigh a contentious plan to overhaul the country’s judiciary, it appeared Tuesday that the country’s ruling party may get the votes it needs in the Senate to jam through the proposal.